Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family
of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart …

Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …

Summary Background Proton pump inhibitors (PPIs) are widely used to treat and prevent
acid‐related disorders. Despite high efficacy, PPI safety has been increasingly scrutinised …

Abstract Proton Pump Inhibitors are used widely to manage many gastric acid-related
conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett's esophagus …

Aims The aim was to perform an umbrella review to summarise the existing evidence on
proton‐pump inhibitor (PPI) use and adverse outcomes and to grade the certainty of …

Some things change. Much remains the same. Proton pump inhibitors (PPIs) continue to be
the mainstay of treatment of acid-related disease, especially gastroesophageal reflux …

Abstract Background Proton pump inhibitors (PPIs) are commonly prescribed for the
treatment of acid-related disorders. In the context of coronary artery disease (CAD), PPIs are …

Abstract Background and Aims Observational research has indicated that proton pump
inhibitors (PPIs) might increase the long-term risk of cardiovascular events. This study …

Background: The safety and efficacy associated with the use of proton pump inhibitors (PPIs)
by patients with coronary artery disease receiving dual antiplatelet therapy (DAPT) remain …